Showing results (391-400 of 736) with videos related to
Sort By:
Pageof 74
Journal of Neurosurgery|November 1, 1987
The effect of nutritional support on outcome from severe head injuryB Young, L Ott, D Twyman, et al.Neurobiology of Aging|February 2, 2013
Multiple clinically relevant hormone therapy regimens fail to improve cognitive function in aged ovariectomized rhesus monkeysMark G Baxter, Mary T Roberts, Nancy A Gee, et al.Cell|August 25, 1989
Direct activation of the serine/threonine kinase activity of Raf-1 through tyrosine phosphorylation by the PDGF beta-receptorD K Morrison, D R Kaplan, J A Escobedo, et al.Journal of Neuropathology and Experimental Neurology|March 11, 2014
Age-related brain expression and regulation of the chemokine CCL4/MIP-1β in APP/PS1 double-transgenic miceMin Zhu, Joanne S Allard, Yongqing Zhang, et al.Oncogene|May 1, 1990
Probing structure and function of the raf protein kinase domain with monoclonal antibodiesW Kolch, E Weissinger, H Mischak, et al.The EMBO Journal|November 1, 1993
Raf-1 is required for T cell IL2 productionH Owaki, R Varma, B Gillis, et al.Clinical Trials (London, England)|November 11, 2005
The Women's Health Initiative Study of Cognitive Aging (WHISCA): a randomized clinical trial of the effects of hormone therapy on age-associated cognitive declineSusan M Resnick, Laura H Coker, Pauline M Maki, et al.Hepatology (Baltimore, Md.)|April 16, 1998
p21Ras downstream effectors are increased in activity or expression in mouse liver tumors but do not differ between ras-mutated and ras-wild-type lesionsA Kalkuhl, J Troppmair, A Buchmann, et al.Biochimica Et Biophysica Acta|November 18, 2010
Pore-forming activity of BAD is regulated by specific phosphorylation and structural transitions of the C-terminal partLisa Polzien, Angela Baljuls, Heide-Marie Roth, et al.Cutis|September 1, 1996
Alternative therapies commonly used within a population of patients with psoriasisA B Fleischer, S R Feldman, S R Rapp, et al.Pageof 74